Dendreon (DNDN)

Trading Advice for DNDN

#1 for Trading Advice: 

Stock Traders Daily is ranked #1 for “Trading Advice” by Google. Our services include the most accurate leading longer term stock market and economic indicator ever developed (The Investment Rate), and proactive strategies that help people manage risk and realize positive returns in any market environment, regardless of economic conditions, and without sacrificing time or lifestyle.

Report Details

Dendreon (DNDN) Stock Quote Price Graph

Dendreon (DNDN) Stock Quote Information

Dendreon Corporation, a biotechnology company, engages in the discovery, development, and commercialization of therapeutics to enhance cancer treatment options for patients. The company offers active cellular immunotherapy, monoclonal antibody, and small molecule product candidates to treat various cancers. Its product candidates comprise Provenge (sipuleucel-T), an active cellular immunotherapy that has completed three Phase III trials for the treatment of metastatic, castrate-resistant prostate cancer; and (lapuleucel-T), an investigational active immunotherapy for the treatment of patients with bladder, breast, ovarian, and other solid tumors expressing HER2/neu; and TRPM8, a small molecule agonist to Trp Ion Channel, for multiple cancers. The company also has a range of products in preclinical studies, which include Carcinoembryonic antigen for the treatment of breast, lung, and colon cancer; and Carbonic AnhydraseIX for the treatment of kidney, colon, and cervical cancer. Dendreon Corporation was founded in 1992 and is headquartered in Seattle, Washington.

Trading Advice for DNDN

     
  1. Buy signals for DNDN
  2. Sell Signals for DNDN
  3. Risk controls are integral
  4. Make money trading DNDN
Download My Free Report
Contact Us
Contact Us